Negative selection of thymocytes only occurs if next to signals through the TCR, additional antigen-presenting cell (APC)-derived signals are also provided. It has been unclear which molecular interactions lead to the generation of these signals. In particular, the involvement of CD28 and its ligands B7-1 and B7-2 has been controversial. In the present study, we re-address this issue and first confirm that cross-linking CD28 molecules on thymocytes can indeed complement TCR-derived signals for induction of deletion upon TCR engagement with antibodies. Furthermore, we extend these findings by documenting that also peptide agonist-induced deletion can be co-stimulated by antibody-mediated engagement of CD28. Additionally, blocking B7-1 or B7-2 reduces negative selection induced by both anti-CD3 and peptide agonist in suspension cultures and in fetal thymic organ culture. At the same time, prominent co-stimulation of TCRinduced deletion could be provided by a B7-negative cell line. Together these results definitively demonstrate that CD28-B7 interactions can function to co-stimulate induction of clonal deletion, while yet to be identified B7-independent co-stimulatory signals can fulfil this function as well.
Introduction
Development of the mature T cell repertoire in the thymus is characterized by two selection processes resulting in a pool of mature T cells that is self restricted but not autoreactive. Thymocytes that express TCR with inherent affinity for complexes of self peptides bound to self MHC are rescued from programmed cell death in a process called positive selection (1) (2) (3) (4) (5) (6) . Additionally, negative selection by induction of apoptosis occurs for those thymocytes bearing receptors that react strongly to self (7) (8) (9) . Both processes depend on interactions between the TCR on CD4 + CD8 + CD3 + thymocytes and self peptides associated with MHC molecules on thymic APC (10, 11) .
It is clear that a decisive role in positive and negative selection lies in the affinity of the TCR for a given peptide-MHC complex together with the density at which this peptide is presented (12) (13) (14) . On the other hand, it has been suggested that different types of antigen-presenting cells (APC) are associated with these two selection processes, implying that additional variables are involved. Radiation bone marrow chimera studies indicated that, with respect to induction of positive and negative selection, the thymus appears compartmentalized. Thus, the radiation-resistant thymic epithelium was found responsible for positive selection, whereas negative selection was induced by APC derived from the bone marrow (i.e. cells of hematopoietic origin) (15) (16) (17) (18) . The differential ability of thymic APC to invoke either positive or negative selection may be the result of several features. First, the MHC levels on the APC can be expected to influence the density at which peptide-MHC complexes can occupy TCR on the thymocytes. Second, expression of adhesion molecules is likely to be involved, as for instance antibodies against LFA-1 and ICAM-1 have been shown to block negative selection (19) . Finally, expression of co-stimulatory molecules might be a crucial determinant, making APC specifically suited for one of the two selection processes.
In line with a proposed role for co-stimulation in thymocyte selection, it has been demonstrated that signals through the TCR are by themselves insufficient for clonal deletion (20, 21) . It is unclear, however, whether the co-stimulatory molecules involved in clonal deletion are the same as those operative in activation of mature T cells. In favor of this notion is the observation that cells which abundantly express ligands for
The aim of the present study was to re-address the hypothesis that co-stimulatory interactions involved in activation can also fulfil this function for clonal deletion. We reasoned that if our hypothesis was correct, it should be possible to induce clonal deletion in a co-stimulation-deficient setting through TCR triggering together with ligation of CD28. For this, an in vitro suspension culture system was used, in which thymocytes from 2B4 TCR-transgenic mice (6) were stimulated in various ways. These transgenic thymocytes respond to presentation of the 88-104 C-terminal peptide from pigeon cytochrome c (p17) in the context of I-E k class II molecules by rapid onset of apoptosis. With this culture system, we show that CD28 on DP thymocytes is indeed capable of generating signals sufficient to complement TCR-derived signals, such that a full stimulus for induction of apoptosis ensues. We demonstrate that CD28 can perform this function not only when the TCR is triggered by antibody-mediated cross-linking, as previously reported (21) , but also in an antigen-specific setting. Moreover, we show that blocking the ligation of CD28 with its ligands, B7-1 and B7-2, reduces the percentage of cells that are deleted upon peptide agonist presentation both in suspension culture and in fetal thymic organ culture (FTOC). Therefore our data suggest, in contrast to earlier reports by us and others (20, (26) (27) (28) (29) (30) , that costimulatory interactions involved in activation of mature T cells also operate in negative selection. The finding that blocking of B7-1/2 causes a substantial reduction in peptide-induced deletion even in the intact thymus implies a physiological role for CD28-mediated signals in negative selection.
Methods

Mice
All mice were bred at the Netherlands Cancer Institute under specific pathogen-free conditions. Experiments were performed with thymuses from (2B4ax2B4P)F! TCR-transgenic mice (6) on the C57BL/6 background. For suspension culture experiments, 3-to 6-week-old mice were used.
Antibodies and reagents
For tissue culture the following Protein A-purified antibodies were used: GK1.5 (anti-CD4; 38); 11-4-1 (anti-K k ; 39), 14-4-4s (anti-l-E k ; 40); 1G10 (anti-B7-1; 43), GL1 (anti-B7-2; 44) and GL3 (anti-y6TCR; 45) were kindly provided by Drs L H. Glimcher, K. S. Hathcock and L. A. Gravestein respectively. Whole rat Ig was obtained from Caltag (South San Francisco, CA). In some instances, ammonium sulfate precipitates from supernatants of hybridomas were used; they were grown in media containing nutridoma-NS serum-free media supplement instead of FCS: 53-6.7 (anti-CD8; 41); 37.51 (anti-CD28; 24) and 145-2C11 (anti-CD3e; 42).
The following antibodies and reagents were used for flow cytometry: 2.43-FITC (anti-CD8; 46), anti-CD4-phycoerythrin (Caltag), KJ25-FITC (anti-V p 3; 47), anti-B7-1-FITC (PharMingen, San Diego, California), anti-B7-2-FITC (PharMingen) and streptavidin-tricolor (Caltag).
Pigeon cytochrome c peptide 88-104 (p17) was produced by the automatic peptide synthesizer Milligen 9050 as described (48) . Synthesis was carried out at the Biochemistry Department of the Netherlands Cancer Institute.
Cell lines
DAP3.3C1 (49) is an MHC class ll-negative fibroblast cell line derived from H-2 k mice; DCEKhi7 is a daughter cell line of DAP3.3C1 transfected with l-E k (J. Miller and R. H. Germain, unpublished results). P815 is a mastocytoma cell line (ATCC); PIEK was generated from P815 by co-transfection of two pcEXV-3 plasmids containing mouse MHC class II E a and Ep k (50) , respectively, together with the mouse invariant chain gene (51) under control of a p actin promotor in pFM92 plasmid. Cells were transfected by electroporation. LEC is a B cell lymphoma derived from CBA/Ht mice (52) .
In vitro deletion assay
Thymocytes were brought into single cell suspension in Iscove's modified Dulbecco's medium (Gibco/BRL, Paisley, UK) supplemented with 10% FCS (BioWhittaker, Verviers, Belgium), 2X10~5 M 2-mercaptoethanol (Merck, Darmstadt, Germany), 100 U/ml penicillin and 100 |ig/ml streptomycin.
Between 2 and 4X10 5 thymocytes were cultured in 96-well flat-bottom plates for 12-18 h (as indicated in the figure legends) at 37°C in a humidified incubator containing 5% CO 2 in air. Spontaneous appearance of EtBr + cells was between 25 and 40%. For antigen-specific deletion thymocytes were incubated with 1x10 5 APC (and 1X10 5 costimulators where indicated) per well. Antibodies and peptides were added soluble in these experiments. In some experiments APC have been fixed with ECDI (Sigma, St Louis, MO). Fixation was carried out essentially as described (53) . Briefly, 1-2x10 7 cells were washed three times in PBS and sub-sequently incubated for 1 h on ice in 1 ml of 0.9% NaCI containing 75 mM ECDI. After this the cells were washed four times in medium. For antibody-mediated deletion, wells were coated for at least 2 h with 50 nl of a 50 ng/ml antibody solution in PBS. Subsequently, plates were washed three times with PBS before thymocytes were added. DP thymocytes were purified for these experiments by panning on Petri dishes that had been coated with 25 (ig/ml 53-6.7 antibody in PBS overnight. Thymocytes were incubated on these plates for 1 h in medium at 4°C. Subsequently, non-adherent cells were removed by repeated gentle addition and removal of medium until no more floating cells were seen under the microscope. After this the adhering cells were isolated by vigorous pipetting.
Flow cytometry
Maximally 1X10
6 cells per sample were resuspended in PBS containing 0.5% BSA and 0.02% sodium azide. Antibody was added in 20 nl per sample, after which the cells were incubated on ice for 30 min followed by two wash steps. Incubation with biotin-labeled antibodies was followed by incubation with streptavidin-TriColor. For measurement of deletion thymocytes were after surface staining exposed to 1 ng/ml ethidium bromide (Sigma) in 50 \i\ for 30 min as described (54) .
Between 1X10 4 and 2.5X10 4 cells were analyzed per sample on a Becton Dickinson FACScan using Lysys II software. DCEK and PIEK APC were gated out electronically on the basis of FSC/SSC pattern.
Apoptosis measurement was carried out according to the protocol published by Nicoletti et al. (55) for staining nuclei with propidium iodide in hypotonic buffer.
FTOC
Thymic lobes from (C57BL/6 2B4axB10.A 2B4P)F, embryos at day 16 of gestation were excised and placed on the surface of 0.8 urn polycarbonate membrane Nucleopore filters (Poretics, Livermore, CA). Filters were supported by a gelfoam gelatin sponge (Upjohn, Kalamazoo, Ml). Each sponge was placed in a well of a six-well tissue culture plate and soaked in 3 ml of culture medium. The culture medium was freshly made Iscove's supplemented with 20% FCS, non-essential amino acids (Gibco/BRL), 2X10~5 M 2-mercaptoethanol (Merck), 100 U/ml penicillin and 100 ng/ml streptomycin, and 4 mM L-glutamine. Starting from 1 day after excision of the lobes, antibodies against B7-1 and B7-2 (5 ng/ml each), whole rat Ig (20 |xg/ml) or 11-4-1 (20 ng/ml) were added daily. On day 3, p17 or anti-CD3 were added to the organ cultures. After 15 h thymic lobes were harvested for analysis.
Results
Clonal deletion of thymocytes requires co-stimulation
In vitro co-culture of thymocytes, derived from TCR-transgenic mice, together with APC expressing appropriate MHC molecules is a well established system for studying clonal deletion (56, 57) . The usage of TCR-transgenic animals allows visualization of peptide-mediated events, whereas the in vitro culture system makes it possible to reduce the complexity of the U EtBr Fig. 1 . In vitro clonal deletion assay. Thymocytes from 2B4 TCRtransgenic mice were used (on the non-selecting C57BL/6 background), of which -95% express the transgenic receptor specific for the 88-104 C-terminal peptide from pigeon cytochrome c (p17) in the context of I-E k . These thymocytes were cultured for 12-18 h together with an l-E k -transfected fibroblast cell line (DCEK hi7) with different concentrations of p17. Shown are dot plots of CD8 (detecting all DP thymocytes) versus EtBr (detects loss of viability). The concentration of p17 used is shown in the upper right corner of each dot plot. Numbers above the CD8 + EtBr and the CD8 + EtBr + regions indicate the percentages of cells falling into those regions. thymic microenvironment. In the present study we made use of thymocytes derived from mice that are transgenic for the TCR of the 2B4 clone (6) . Over 90% of these thymocytes recognize the 88-104 C-terminal peptide (p17) from pigeon cytochrome c in the context of I-E k . Positive selection of thymocytes with this receptor occurs in mice expressing I-E k , but not in mice with an H-2 b haplotype. In the absence of a positively selecting restriction element accumulation takes place of CD4 + CD8 + CD3 + cells, generating a large window for selection studies. Therefore, all our suspension culture experiments were performed with thymocytes from 2B4-transgenic mice crossed onto the non-selecting C57BL/6 background.
Initiation of deletion of thymocytes is characterized by down-modulation of CD4 and CD8 molecules (56) . However, this phenomenon has also been observed in thymocytes not committed to apoptosis (20) . Therefore, we chose to screen our deletion assays by two-color flow cytometry measuring CD8 expression and EtBr uptake. Because in 2B4 TCRtransgenic mice on the non-selecting C57BL/6 background very few CD4 + single-positive thymocytes exist, CD8 is a suitable marker for detection of DP cells. All or most CD8ã re double-negative precursors in this setting. EtBr is a DNA intercalating dye which can only enter into cells that have reduced membrane integrity, due to loss of viability (54) . Staining with this dye strongly separates viable from non viable cells (Fig. 1) , thereby allowing sensitive measurement of deletion.
Presentation of p17 on DCEK, a fibroblast cell line transfected with I-E k , leads to a dose-dependent decrease in live DP cells, identified as CD8 + EtBr. This decrease is mirrored by an increase in CD8'°EtBr + cells (Fig. 1) . In some experi-ments the loss of CD8 + EtBr cells was not associated with a proportional increase in CD8 + EtBr + cells. Possibly, this was the result of a specific disappearance of these latter cells either because of adherence to the APC, phagocytosis or desintegration. An alternative explanation could, however, be that the loss of CD8 + EtBr cells was partially due to downregulation of CD8 molecules by thymocytes not committed to die. On the basis of the cell yields we obtained we could not definitively discriminate between these possibilities. For this reason we discarded experiments in which the loss of CD8 + EtBr cells was not matched by an increase in CD8 + EtBr + cells.
In order to demonstrate the requirement for co-stimulatory signals in induction of deletion, we analyzed the capacity of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (ECDI)-treated DCEK to function as APC for induction of deletion. Fixation of APC destroys their ability to co-stimulate activation of mature T cells, without severe disruptive effects on peptide presentation (53) . Moreover, it has been shown that it is possible to generate responses of mature T cells with fixed APC in a three cell system. In this setting, peptide presentation occurs by the fixed APC, whereas co-stimulation is delivered in trans by APC that lack permissive MHC molecules (58) .
Clearly, fixation of DCEK abrogates their ability to delete thymocytes (Fig. 2) . That this is due to destruction of costimulatory capacity and not the result of disruption of peptide presentation is demonstrated by the fact that the deletional response is restored by addition of DAP3.3C1 (Fig. 2) . These cells do not express MHC class II (59) and therefore cannot present p17 to the thymocytes (data not shown). Thus, in confirmation of earlier results (20) , induction of negative selection requires co-stimulation, which can be provided in trans. Not all cells are capable of delivering such co-stimulatory signals in this setting, as illustrated for instance by the inability of P815 mastocytoma cells to co-stimulate in trans (Fig. 2) .
Co-stimulatory signals for deletion can be provided by CD28
The above data document that activation and deletion share a requirement for co-stimulation. An important co-stimulatory signal involved in activation of mature T cells is generated by ligation of CD28 on the T cell with its B7-1 and B7-2 counterreceptors on the APC (60) (61) (62) (63) (64) . Blocking this interaction reduces T cell responses, whereas antibody-mediated crosslinking of CD28 can complement signals through the TCR and prevent induction of anergy in T cell clones (65) . It was reported earlier (21) that also on DP thymocytes, engagement of CD28 molecules leads to the generation of signals that can complement those generated by anti-CD3 for full induction of deletion. We first confirmed (data not shown) that anti-CD28 co-stimulates anti-CD3-induced deletion of DP thymocytes, and also found through propidium iodide staining, again in agreement with Punt et al. (21) , that the specific deletion of DP thymocytes by CD3 and CD28 cross-linking occurs via an apoptotic mechanism.
It is unclear whether clonal deletion resulting from crosslinking the TCR on thymocytes with antibodies is representative of deletion that is induced by recognition of antigen on APC. In Bcl-2-transgenic mice, for example, the former is blocked whilst the latter appears to be unaffected (66 different signal transduction pathways may be activated by the two different ways of triggering deletion. We therefore investigated whether cross-linking CD28 molecules on thymocytes could also function to co-stimulate deletion if the signal through the TCR was provided by engagement of peptide plus MHC. In order to do this, we chose to use PIEK cells (P815 transfected with I-E k ) as APC for two reasons. First, these cells express high levels of Fc receptors (CD16) and therefore are capable of presenting antibodies to thymocytes. In addition, the parent cell line of PIEK, P815, was found to be ineffective in providing co-stimulation in trans (Fig. 2) . Therefore, PIEK could be expected to be an inefficient inducer of deletion, allowing us to optimize deletion by provision of co-stimulation. As shown in Fig. 3 , presentation of p17 on PIEK cells to purified thymocytes, without exogenously added co-stimulation, leads to maximally 40% deletion. CD3 crosslinking on these same thymocytes by plate bound antibody did not lead to deletion (data not shown), demonstrating that these thymocytes had been sufficiently depleted of endogenous APC. While these results indicate that PIEK cells are not completely co-stimulation-deficient, a large portion of the thymocytes seems to interact with the p17 presented on pl7 cone (jig/ml) costimulus:
-~°"-none -»-anti-CD28 -°-control hamster IgG the PIEK cells without receiving sufficient co-stimulation. This is documented by the fact that they have down-regulated CD8, yet do not become EtBr + (results not shown). Addition of anti-CD28 significantly enhances deletion induced by presentation of p17 on PIEK (Fig. 3) . Not only is the peptide dose-response curve shifted to 100-fold lower concentrations with anti-CD28, but also the amount of deletion under saturating p17 concentrations is increased when extra co-stimulation is provided by anti-CD28 antibody. This enhancing effect does not occur when control hamster antibody is added (Fig.  3) . Also, upon presentation of anti-CD3 by P815 no effect was found by addition of anti-CD4 (data not shown), whereas anti-CD28 significantly enhanced deletion.
Involvement of B7-1 and B7-2 in induction of deletion by APC
Having established that mAb-mediated engagement of CD28 can provide co-stimulatory signals for negative selection, the question remains whether physiological engagement of this molecule by its ligands can allow this process to occur. In several studies, blocking B7 molecules with CTLA4-lg does not abrogate deletion, implying that engagement of these molecules is not necessary for deletion (20, 26, 27) . Also, CD28-deficient mutant mice exhibit normal negative selection of certain self-reactive T cell specificities (28) (29) (30) , arguing against a prerequisite role for CD28 in thymic deletion. The models used so far, however, may have been insufficiently sensitive to allow visualization of a contribution of CD28 to deletion. Status quo analysis of deletion in CD28 mutant mice would provide ample opportunity for alternative co-stimulatory pathways to exert their effect (28) (29) (30) , as would the longer incubation periods of thymocytes with the deleting antigen we and others previously used (20, 27) . Also, visualization of a role for CD28 in deletion will be critically dependent on the type of APC expressing a given self-antigen, and the Mis and class l-restricted peptides used previously (28, 30) may have been presented by APC not expressing ligands for CD28.
Together, these arguments presented an incentive to reexamine whether B7 molecules are involved in negative selection in the intact thymus in a FTOC model. In contrast to our previous approach (27) , we now first saturated fetal thymic lobes with antibodies against B7-1 and B7-2, and subsequently incubated the lobes with peptide or anti-CD3 for only 15 h. When analyzing these lobes with ethidium bromide, we observed too much variation between groups treated similarly to allow clear judgement of effects of anti-B7 treatment (data not shown). A likely explanation for this is that small parts of fetal lobes become necrotic, due to imperfect penetration of nutrients and/or oxygen. As ethidium bromide staining cannot distinguish between necrotic and apoptotic cells, we therefore analyzed the results from the organ cultures by staining with propidium iodide in hypotonic buffer. Indeed, after staining the samples with propidium iodide in hypotonic buffer, we observed much less variation as well as much lower background cell death. Using this detection method, we observed that anti-CD3 induced apoptosis in B10.A fetal thymic lobes was substantially blocked by anti-B7 treatment, but not by treatment with control antibodies (Fig. 4A) . Similarly, we found that anti-B7 treatment leads to a clear reduction in the amount of deletion induced by p17 in lobes derived from 2B4 TCR-transgenic mice (Fig.  4B) . These results document that, in contrast to earlier reports, B7 molecules are indeed used by APC in the intact thymus for induction of negative selection.
Since blocking of B7-1/2 did not abrogate deletion in the FTOC completely, we argued that skewing of the costimulatory requirements towards a role for B7-1 or B7-2 by the use of clonal populations of APC expressing B7-1 (DCEK) or B7-2 (LEC) would more prominently allow visualization of B7-1/2 involvement. To test this prediction, we performed experiments in which thymocytes were exposed to p17 on DCEK or LEC cells in the presence of blocking antibodies against B7-1 and B7-2. As shown in Fig. 5(A) , blocking B7-1 and B7-2 together diminishes the amount of deletion induced by DCEK. Because we failed to detect B7-2 expression on DCEK by flow cytometry, the effect of the blockade is presumably due to blocking the accessibility of B7-1. This notion is corroborated by the fact that antibodies to B7-1 alone have a comparable reducing effect on deletion to the effect with both antibodies. In addition, antibodies against B7-2 have no effect on deletion mediated by DCEK (data not shown). That B7-2 molecules can perform a similar role as B7-1 in clonal deletion can be concluded from the results obtained with LEC as APC. LEC is an H-2 k B cell lymphoma that highly expresses B7-2 but not B7-1 (as determined by flow cytometry). Addition of anti-B7-2 antibody in the assay leads to a marked reduction in the amount of deletion (Fig.  5B) . Anti-B7-1 does not appear to have any effect on induction of deletion by this B cell lymphoma. Together, these findings document a dominant role for B7-1 and B7-2 in deletion when antigen is presented only by B7-expressing APC. In contrast to the results obtained for B7-1 with DCEK and for B7-2 with LEC as APC, we found no effect of either antibody on deletion induced by PIEK (Fig. 5C ). PIEK cells do not express either B7-1 or B7-2. These results illustrate that different types of APC employ different molecules for costimulation of deletion. Thus, while LEC appears to heavily depend on B7-2 for its co-stimulatory ability, DCEK and especially PIEK must clearly express other, as yet unidentified but prominent co-stimulatory molecules. This finding provides a rational explanation for the lack of B7 participation in deletion reported previously, as well as for our observation that not all deletion in the thymus can be blocked by anti-B7-1/2 (Fig. 4) .
Discussion
For efficient establishment of tolerance it is necessary that interactions leading to T cell activation by self antigens in the periphery are prevented through clonal deletion of the pertinent thymocytes. It could, therefore, be expected that qualitatively similar interactions are involved in activation of T cells in the periphery and negative selection in the thymus. Indeed, it has been demonstrated that the range of peptide doses and affinities required for activation and deletion overlap, with a safe margin on the side of tolerance (22, 57, 67, 68) . Also, the potency of different APC for supporting activation appears to correspond with ability to induce clonal deletion.
From both bone marrow transplantation studies (15) and in vitro experiments (22, 23, 69) it can be concluded that bone marrow-derived cells are the most potent APC for this process. The efficacy of these cells in negative selection could in part be explained by the high MHC levels they express as well as by the localization of these cells in the thymic medulla and cortico-medullary junction. In these regions the DP thymocytes have started to up-regulate their TCR levels, thereby perhaps allowing higher avidity interactions. A contribution to the high efficiency might also be made by co-stimulatory molecules expressed on bone marrow-derived cells. Moreover, the fact that co-stimulatory molecules contribute importantly to the activating capacity of professional APC, together with the above noted similarity of the interactions leading to deletion or activation, would suggest that the co-stimulatory molecules involved in the two processes may be the same or at least overlap. Despite many recent studies addressing this issue (20) (21) (22) (23) (24) (25) (26) (27) (28) it remains difficult to assign a role for specific costimulatory molecules in thymic deletion. We here re-examine the possible contribution of CD28-B7 interactions in negative selection. Engagement of the T cell surface molecule CD28 with its ligands B7-1 and B7-2 leads to generation of a dominant co-stimulatory signal for activation of mature T cells (60) (61) (62) (63) (64) (65) . A role for these molecules in negative selection is suggested by their expression pattern in the thymus. CD28 is expressed at high levels on double-positive thymocytes (24) , whereas B7 is highly expressed (as measured with CTLA-4-lg) on thymic DC, macrophages and B cells (27) as well as on certain medullary epithelial cells (70, 71) . In accordance with this expression pattern, our data demonstrate that ligation of CD28 can complement TCR-derived signals in thymocytes for induction of apoptosis, both if TCR cross-linking occurs by anti-CD3 (as reported previously, 21) or by peptide presentation. Moreover, we show that engagement of B7-1 and B7-2 is involved in deletion induced by certain APC in suspension culture experiments, as well as in the intact thymus. Thus, our data strongly suggest that, at least with respect to involvement of CD28-B7 interactions, co-stimulatory events associated with activation of mature T cells and clonal deletion of thymocytes indeed overlap.
The notion that CD28-B7 interactions are involved in negative selection seems to be inconsistent with the phenotype of CD28-deficient mice. In these mice clonal deletion induced by Mis antigens or by agonist peptide in a TCR-transgenic setting appeared unaffected (28) (29) (30) . It is conceivable, therefore, that the results we obtained from blocking B7 molecules are the consequence of prevented ligation thereof with other thymocyte surface molecules than CD28, such as CTLA-4. However, although CTLA-4-deficient mice have a dramatic phenotype in the thymus (72, 73) , perhaps suggesting a role for this molecule in negative selection, we were unable to detect CTLA-4 expression on DP thymocytes. More importantly, we did not observe any effect from anti-CTLA-4 antibodies, alone or cross-linked, on deletion in suspension culture (data not shown). Possibly, therefore, the thymic abnormality of CTLA-4-deficient mice is the consequence of stress associated with the uncontrolled activation of mature T cells in these mice. Other, yet undiscovered, receptors for B7 may be expressed by thymocytes, explaining the effects of the anti-B7 blockade. We contend, however, that these . Blocking B7 molecules on APC in suspension culture reduces the capacity to induce clonal deletion. Thymocytes from 2B4 TCRtransgenic mice were cultured for 13 h with DCEK cells (as in Fig. 1 ) and different concentrations of p17, alone or in the presence of 10 ng/ml anti-K\ 3 ng/ml anti-l-E k or 3 ng/ml anti-B7-1 and 3 ng/ml anti-B7-2. After 14-18 h, cells were harvested and stained for CD8 versus EtBr. Data are expressed as percentage deletion and were calculated as in effects are the result from preventing CD28 cross-linking on the thymocytes, since direct antibody mediated engagement of CD28 results in co-stimulation of deletion. The explanation for the lack of impairment of negative selection in CD28 knock-out mice could then be that the CD28-B7 interaction is one of a redundant set of interactions with the capacity to co-stimulate this process. That other interactions can provide co-stimulation for deletion is also strongly suggested by our observation that certain types of APC, such as PIEK cells, do not express B7 and yet can co-stimulate deletion.
Although we were able to inhibit deletion of DP thymocytes in suspension culture, it is possible that in vivo B7 does not participate in negative selection of cells at this stage of development. Deletion of high-affinity TCR-bearing thymocytes has been reported to occur in the thymic cortex, where very little B7 expression can be detected in the adult thymus. In contrast, B7 expression is abundant throughout the thymus in day 18 embryos. This could be the explanation for the reduction of deletion we obtained when treating FTOC with anti-B7 antibodies. In vivo involvement of B7 in negative selection has been suggested by two previous studies. Thus, deletion of Vp5 + l-E-reactive thymocytes by a subset of thymic medullary epithelial cells was found to be correlated with expression of B7 by these cells (71, 74) . A role for B7 in deletion was also suggested when mice were chronically treated with anti-gp39 (75) . In these mice deletion induced by endogenously expressed antigens was blocked. Since the same was true in gp39-deficient mice, the authors reasoned that this blockade was probably due to a lack of CD40-mediated signal transduction on the thymic APC, resulting in insufficient up-regulation of co-stimulatory molecules on these cells. Indeed, expression of B7-2 was shown to be dramatically reduced in the thymi of these mice (75) , suggesting its involvement in deletion. Alternatively, CD40 directly co-stimulates deletion through a B7-independent mechanism. Separate non-overlapping functions for gp39-and CD28-mediated signal transduction pathways are also suggested to operate in clonal expansion of peripheral T cells (76) .
Besides CD40, another member of the TNFR gene family was recently implicated in negative selection: male CD30-deficient mice expressing a transgenic anti-H-Y TCR exhibit severely reduced clonal deletion in the thymus (77) . Although it was not addressed in this study (77) , CD30 might act as a specific death inducing molecule in thymocytes, similar to Fas on mature T cells. Alternatively, CD30 may function, like CD28, as a co-stimulatory molecule. In that event, the CD30-deficient mice serve to make the point that more than one set of interactions can co-stimulate clonal deletion. Indeed, while deletion of anti-H-Y-specific T cells is diminished in CD30-deficient mice, deletion of Mis-reactive thymocytes is not (77) . Chronic anti-gp39 treatment, on the other hand, does inhibit deletion of Mis-reactive thymocytes (75) . Also, thymi from male anti-H-Y TCR-transgenic CD30-deficient mice are still much smaller than those from females, implicating negative selection driven by the participation of other co-stimulatory molecules (77) .
The question remains why in thymic deletion a requirement for co-stimulation exists (78) . On a theoretical basis one could envisage a system in which deletion would be induced independent of co-stimulation. Such a system would presumably allow removal of more TCR specificities and therefore might offer a safer mechanism for tolerance establishment. A possible reason for the requirement for co-stimulation could lie in the contribution it may make to the discrimination by the thymocyte between positively and negatively selecting interactions. It seems clear by now that an important determining factor between these two selection processes is the peptide dose together with the affinity of the TCR for this peptide + MHC (12) (13) (14) . On the other hand, whether positive or negative selection is induced also depends on the nature of the APC involved, implying a role in selection for accessory molecules that are differentially expressed. The role of costimulation might, in this respect, either be quantitative or a qualitative, but this issue cannot be concluded yet from the currently available information. Although the role of CD28 and B7 in thymic negative selection seems less prominent than in activation of mature T cells, presumably due to redundancy, the results presented in this study clearly suggest that the co-stimulatory signals involved in negative selection and activation overlap. Identification of the signal transduction pathways and transcriptional events linking CD28 engagement on thymocytes to apoptosis will be a major focus for the future. 
